Birt-Hogg-Dub e (BHD) syndrome is a rare genetic disorder characterized by cutaneous fibrofolliculomas, pulmonary cysts and renal cell carcinomas.
human FLCN, Okimoto et al. generated the Nihon rat that spontaneously develops RCC in accordance with Mendelian inheritance. 7 The Nihon rat was later found to harbor a germline mutation in the gene corresponding to human FLCN. 8 Heterozygous Flcn knockout mice and kidney epithelium-specific Flcn depleted mice were generated, which improved our understanding of renal carcinogenesis and renal cyst formation. [9] [10] [11] [12] Initial clinical studies of Japanese patients with BHD syndrome began in the year 2000 with a few case reports describing RCCs and/or fibrofolliculomas. 13, 14 Then, in 2007, Gunji et al. published the genetic and clinicopathological findings of a group of Japanese individuals with lung manifestations of BHD syndrome. 15 They found that a substantial number of patients with recurrent and/or familial pneumothoraces harbor FLCN germline mutations. In contrast to Caucasian patients with detectable fibrofolliculomas, most Japanese patients present with inconspicuous papules that do not lead them to a dermatologist. 16 The majority of previously undiagnosed Japanese individuals could have been suspected of BHD syndrome based on thoracic computed tomography (CT) findings and episodes of recurrent and/or familial pneumothoraces. 17 During video-assisted thoracoscopic surgery (VATS), multifocal transparent pleural/subpleural cysts are found in middle and lower lobes of the lung, which can alert physicians to consider the possibility of BHD syndrome. The pioneering histopathological study of BHD syndromeassociated lung disease was done by Butnor and Guinee in 2006. 18 They described detailed histology of epitheliumlined parenchymal cysts and subpleural cysts modified by rupture. Later we and another Japanese group investigated the histopathological features of BHD syndrome-associated pulmonary cysts in a collection of families. [19] [20] [21] Today, VATS-obtained lung specimens of approximately 100 Japanese patients with BHD syndrome have been provided to us through consultation system of Japanese Society of Pathology (http://pathology.or.jp/) and BHD-NET Japan (http://www.bhd-net.jp/). In this review, we summarize the genetic information obtained from Japanese families with BHD syndrome collected through BHD-NET Japan over a 10-year period and discuss the histopathology of BHD syndrome-associated pulmonary cysts. We then compare BHD syndrome-associated lung disease with emphysematous bullae/blebs and other cystic lung diseases.
DIAGNOSIS
Diagnostic criteria for BHD syndrome were proposed in 2009 by members of the European BHD Consortium. 5 Major criteria include: (i) at least five fibrofolliculomas/trichodiscomas, at least one histologically confirmed, of adult onset, and (ii) a pathogenic FLCN germline mutation. Minor criteria include: (i) multiple bilateral pulmonary cysts with no other apparent cause, with or without spontaneous pneumothorax; (ii) renal cancer: early onset (<50 years) or multifocal or bilateral RCC, or RCC of mixed chromophobe and oncocytic histology; (iii) a first-degree relative with BHD syndrome. In the proposed criteria, cutaneous features were more weighted than pulmonary manifestations. The criteria cover characteristic manifestations in Caucasian families, but are not suitable for Japanese Asian patients whose major complaints are repeated pneumothoraces. Our epidemiologic study revealed that cutaneous papules were not the major complaint in most individuals. 16 The papules are generally subtle and rarely alert dermatologists to the possibility of BHD syndrome. A recent dermatological study of Japanese patients by Iwabuchi et al. revealed that cutaneous manifestations were detectable in around 80% of affected Japanese patients with the help of dermoscopy. 22 Inconspicuous papules in Japanese populations, therefore, can alert us to the possibility of BHD syndrome if patients are carefully examined by dermatopathological specialists with expertise in genetic disorders. Almost all affected members have radiologically determinable cysts and/or microscopic pulmonary cyst, and approximately 20-30% of carriers develop renal tumors. 16 Since pathogenic FLCN variants are detectable by sanger sequencing analysis in around 90% of affected family members, definitive diagnosis of BHD syndrome is usually confirmed with genetic testing. 23 Nearly 150 pathogenic FLCN variants have been identified worldwide. 23 The most frequent pattern is a frameshift mutation within a coding exon region. Less frequent types include nonsense, in-frame deletion, missense, and splicesite mutations. In genetic testing of 199 Japanese populations and one Taiwanese population, 48 different pathogenic variants were detected by our group (Table 1) . Japanese patients' mutations are concentrated in exons 11-13. 16 The mutation c.1285dupC in exon 11, which is the most frequent mutation in Caucasian and Chinese families, is also the most frequent in Japanese families. 4, 24 In addition to the aforementioned mutation types, intragenic deletions and duplications are also catalogued in the Leiden Open Variation Database (https://databases.lovd.nl/ shared/genes/FLCN) and in a review by Schmidt and Linehan. 23 A few intragenic deletions involve non-coding exons and/or putative promoter regions. 25, 26 Targeted next generation sequencing analysis and multiplex ligation-dependent probe amplification assays allow us to detect affected regions that cannot be found by sanger sequencing. 25, 26 Intronic splice-site mutations are expected to result in premature protein truncation. Most splice-site mutations involve the 3 0 -end of the affected intron (acceptor site), and are predicted to cause exon skipping in FLCN mRNAs. 
LUNG MANIFESTATION AND THERAPEUTIC APPROACHES
In our epidemiologic study of 312 individuals, the patient age at the time of initial pneumothorax ranged from 15 to 69 years and the median age of initial pneumothorax was 37.9 years. 16 Most patients experienced initial episodes of pneumothorax at ages younger than 45 years. Children under 10 years of age rarely have BHD syndrome-associated symptoms; however, a substantial number of patients experience a pneumothorax in their teenage years. 32 It remains poorly understood when the pulmonary cysts start to develop in the teenagers who experienced pneumothorax, because screening CT is not generally recommended for pre-symptomatic children.
Exposure to alterations of air pressure, such as during flying and diving, may increase the risk of pneumothorax. 33 Several patients in our study experienced pneumothorax during surgery for pneumothorax, renal tumors, or other visceral diseases that are associated with perioperative mechanical ventilation. In addition to changes in air pressure, changes in pulsation and hemodynamics may also be associated with the development of pneumothorax. Six female patients in our study experienced pneumothoraces during pregnancy or perinatal periods, and one had a pneumothorax during the second and third deliveries.
Patients with their first pneumothorax are conservatively treated with chest tube decompression, but many need surgical intervention due to intractable pneumothorax. Local wedge resection of pleural/subpleural cystic lesions may not successfully protect patients from repeated pneumothoraces, because multiple cysts are distributed bilaterally near the mediastinum and/or diaphragmatic regions of the lower lobes. Pleurodesis appears to reduce the risk of recurrent pneumothorax. 34 We and another Japanese group reported that bioabsorbable pleural coverings successfully protected patients from intractable pneumothoraces. 35, 36 The latter method may enable patients to safely undergo VATS years later if they develop other lung diseases.
PATHOLOGY OF PULMONARY CYSTS
Pathologists are requested to distinguish BHD syndromeassociated pulmonary cysts from bullae/blebs and other cystic lung diseases; however, pathological diagnosis may be limited by a dearth of information on the specimen. Microscopic findings should always be compared to radiological findings, which allows us to determine the probability of various cystic lung diseases. Miscellaneous rare cystic lung diseases that mimic BHD syndrome-associated pulmonary cysts are discussed later. The BHD syndrome-associated peripheral lung tissue that is resected by VATS generally contains pleural/subpleural cysts, but may not have intraparenchymal cystic lesions. Pleural/subpleural cyst walls often extend toward the thoracic cavity and are modified by mechanical stress, which causes irregular thickening, hyalinization, rupture and secondary inflammation. 37 Invagination of mesothelial cells subsequent to pneumothorax may result in the formation of secondary bulla/bleb-like cystic spaces, which may mask characteristic features of BHD syndrome-associated cysts. 37 Compared to subpleural cysts, intraparenchymal cysts are less affected by inflammation, providing us with reliable clues that suggest BHD syndrome. 21 Immunostaining for TTF-1, Napsin A, pro-surfactant protein C and CAM5.2 confirms the alveolar epithelial nature of the lining cells. Careful observation is needed because non-specific bullae/blebs may also have partial epithelial lining following the regenerative process. At present, there is no specific antibody that distinguishes BHD syndrome-associated cysts from others. 20 We and others have discussed the histopathological characteristics of BHD syndrome-associated lung lesions. 18, 21, 37 Although there is controversy regarding the process of lung cyst formation, the cyst features that suggest BHD syndrome are as follows: (i) the inner surface of the cyst is lined by a layer of benign-looking flat alveolar epithelium, which is in contrast to inflammatory diseaseassociated lung cysts that are predominantly lined by cuboidal type II pneumocytes; (ii) the cyst wall is thin, lacking inflammatory reactivity, and is frequently incorporated into the stroma of interlobular septa, bronchovascular bundles and/or visceral pleura; and (iii) the cyst may have intraluminal thin alveolar septum-like structure(s), dividing the air space into two or more sections.
In this review, we show macroscopic and microscopic features of an autopsied BHD syndrome-associated lung together with thoracic CT images to better display the threedimensional structure of cysts. To the best of our knowledge, there have been no pathological studies of whole lungs in patients with BHD syndrome. In the current review, the patient died of prostate cancer at the age of 81. He was a never smoker and had episodes of pneumothorax at ages 35 and 42, multiple renal tumors at age 76, and was diagnosed with BHD syndrome by genetic testing at age 79. Thoracic CT scanning performed while he was alive demonstrated multiple cysts in all lobes, including both subpleural and intraparenchymal regions, preferentially located in the lower lobes (Fig. 1a) . In the autopsied lung, the uneven distribution of cysts was confirmed, i.e., a tendency to concentrate in the mediastinal and lower M. Furuya and Y. Nakatani regions (Fig. 1b) . The cysts tended to be larger in size toward the lower mediastinal/central side of the lung.
Close examination demonstrated that a number of cysts in the pulmonary central/hilar regions abutted large bronchi and vessels, developing mostly devoid of intervening peripheral lung parenchyma (Fig. 2a) . The bronchi adjacent to the cysts were neither dilated nor continuously connected with the cysts. Multiple cysts localized in a back-to-back fashion with thin partitions. The cyst walls were very thin with a smooth and glistening inner surface. Larger cysts often enveloped trabecular structures including bronchi and vessels, which traversed the cystic space and connected to the lung parenchyma at both ends (Fig. 2b) . Small unruptured cysts tended to involve perilobular structures, including interlobular septa and/or bronchovascular bundles (Fig. 2c) . Having intimate association with interstitial components at one or more points, most cysts were slightly distorted, looking like rugby balls, or were oval rather than round. Notably, all cysts were well-demarcated with no emphysematous changes in the background.
The results of three-dimensional macroscopic and microscopic analyses of the autopsied lung in this study help provide a deeper understanding of the radiological and pathological findings previously described using CT scans and VATS specimens. 17, 21, 37, 38 We found: (i) A typical parenchymal cyst sits astride interlobular septa, with a lining of benign-looking alveolar epithelium on the inner surface (Fig. 3a,b) ; (ii) Multiseptation, a radiological feature of larger BHD syndrome-associated cysts, 38 is histopathologically of two different origins, i.e., one type of septum is formed by the juxtaposition of two expanding cyst walls with compressed alveolar structures between them (Fig. 3c) , and the other type is formed de novo from alveolar septum-like structures as an inherent feature of BHD syndrome- Lung pathology of BHD syndrome 5 associated pulmonary cysts (Fig. 3d,e) ; and 3) The tendency for these cysts to have rugby ball-like or oval rather than round shapes may be explained by their extension along the interstitial tissue surrounding bronchial trees and blood vessels.
POSSIBLE MECHANISM OF CYST FORMATION
The mechanisms underlying pulmonary cyst formation remain unclear. Loss of Flcn in the lung epithelium of Flcn f/f : SP-C-Cre mice resulted in the downregulation of LKB1 and E-cadherin, indicating that FLCN deficiency alters epithelial adhesion and survival, thereby contributing to alveolar enlargement. 39 Experiments using human bronchial epithelial cells demonstrated increased cell-cell adhesion forces when FLCN was silenced. 40 Plakophilin-4 (p0071) is a candidate protein that alters cell adhesion and migration when FLCN is depleted. 41 Possible mechanisms of cyst formation, including the "stretch hypothesis" that proposes stretch-induced stress at regions with weaker cell-cell adhesion forces, are thoroughly reviewed by Kennedy et al. We would also like to comment on the issue from a histopathological point of view. In BHD syndrome-associated lung disease, immunohistochemical and Western blotting studies using commercially available antibodies demonstrated that cyst-lining epithelium were positively stained for FLCN and the FLCN band was detectable on Western blotting. 19, 20, 43 45 They suggested that FLCN may have a protective function in pneumocytes, and that dysregulated FLCN may affect cellular homeostasis, contributing to lung disease. Finally, based on the histopathological observations thus far described, particularly the unique spatial shift of the boundary between the alveolar and interstitial structures, we would like to emphasize the importance of further investigation of the relevance of FLCN function to epithelial-stromal interactions. It is intriguing that those cysts located in the mediastinal/central region contacting with large bronchovascular bundles having abundant stroma are larger in size than those located in the peripheral region with thin stroma composed of interlobular septa and pleura. Would this signify "the more abundant the stroma are, the larger the cyst grows"?
THE RISK OF LUNG NEOPLASMS
The principal role of FLCN is tumor suppression, and renal carcinogenesis is explained in part by dysregulated mTOR signaling. 23, 46 It remains unclear whether BHD syndrome patients have an increased risk of developing solid lung neoplasms. Two of 11 Flcn heterozygous mice had glandular neoplasms in the lung, which is the background cancer risk in C57BL/6 mice. 9 Some case reports noted the occurrence of lung adenocarcinoma or atypical alveolar hyperplasia (AAH) in BHD syndrome patients as a nonspecific finding. 15, 47 In our epidemiologic study, a total of 22 individuals among 500 BHD syndrome family members (4.4%) had lung neoplasms, although detailed clinicopathological information was not available in most individuals. We collected information on 14 lung neoplasms in 7 BHD syndrome patients. 48 Two of seven patients had two or more independent neoplastic lesions, and a familial occurrence was also noted. 49 The histological types included AAH, adenocarcinoma in situ, minimally invasive adenocarcinoma, papillary adenocarcinoma, micropapillary adenocarcinoma, and micronodular pneumocyte hyperplasia (MPH)-like lesions. Interestingly, all neoplasms were of a peripheral pneumocyte lineage, indicating the possible contribution of FLCN dysfunction to aberrant pneumocyte proliferation. Five tumors demonstrated loss of heterozygosity (LOH) of FLCN, but the wild-type copy was preserved in all cases. Three invasive tumors possessed additional somatic mutations in such genes as epidermal growth factor receptor (EGFR) and KRAS. Therefore, further study is required to clarify whether FLCN alteration alone works as a driving force for the development of precursor lesions such as AAH, or whether FLCN alteration, together with strong driver gene mutations in EGFR and KRAS, facilitates the progression to adenocarcinoma. Tuberous sclerosis complex (TSC) is a genetic disease that carries a risk of cystic lung disease, namely lymphangioleiomyomatosis (LAM). Patients with TSC harbor germline mutations in either TSC1 or TSC2. Both FLCN and TSC1/TSC2 work as mediators of mTOR signaling, although their functions and interacting molecules are different. 46 Multifocal MPH develops in patients with TSC. One patient with BHD syndrome was found to have a single MPH-like nodule in our analysis, therefore it is likely to be a very rare event. The lesion, however, demonstrated a FLCN LOH pattern. 48 Gunji-Niitsu et al. described a clear cell "sugar tumor" of the lung, which belongs to a family of perivascular epithelioid cell tumors (PEComa), in a patient with BHD syndrome. 50 Similar to multifocal MPH and LAM, clear cell sugar tumor is occasionally associated with TSC. Although the frequencies of clear cell sugar tumors and MPH-like nodules in BHD syndrome are currently unknown, these reports allow us to speculate that BHD syndrome-associated lung disease has the potential to develop solid neoplasms similar to TSCassociated lung diseases. Molecular studies of these neoplasms were performed using archived formalin-fixed, paraffin-embedded tissues. A detailed cytogenetic and quantitative gene expression analysis of these tumors awaits further study. Tomassetti et al. reported a pulmonary histiocytoma in a patient with BHD syndrome. 51 Although its genomic status was not investigated, they discussed the possible contribution of a deregulated mTOR pathway to the development of the histiocytoma, because the tumor was positively stained for cathepsin K, one of the immunohistochemical markers of LAM cells. 
MISCELLANEOUS CYSTIC LUNG DISEASES FOR DIFFERENTIAL DIAGNOSIS
Differentiating BHD syndrome-associated cysts from other cystic lung diseases can be difficult. Radiological findings, disease records and family disease histories help pathologists diagnose various cystic lung diseases. Radiologists and pulmonologists have described a series of lung diseases that must be distinguished from one another. 38, 53, 54 Emphysematous bullae/blebs are the most frequent causes of pneumothorax. In addition, radiological findings of several rare diseases mimic those of BHD syndrome-associated cystic lung disease. These include Langerhans cell histiocytosis, LAM, follicular bronchiolitis, lymphocytic interstitial pneumonia (LIP), light-chain deposition disease (LCDD), mucosa-associated lymphoid tissue lymphoma, amyloidosis, chronic hypersensitivity pneumonitis (pigeon breeder's disease) and cystic pulmonary metastases of malignant diseases. 53, 54 Admittedly, we occasionally have to withhold a specific histological diagnosis of cystic lung diseases when FLCN germline mutations are undetectable and the other aforementioned cystic lung diseases are unlikely. Histological diagnostic clues differentiating BHD syndrome-associated cysts and emphysematous bullae/blebs have been attentively studied. 21, 37 In brief, pleural/subpleural cyst walls often exhibit fibrous thickening and chronic inflammation in both BHD syndrome and emphysematous bullae/blebs. BHD syndrome-associated cysts usually have complete or near complete epithelial lining (Fig. 4a,b) . At higher magnification, complex alveolus-like structures of various sizes, either budding from or embedded beneath the inner surface of subpleural cyst walls, are commonly observed (Fig. 4c,d ). Emphysematous bullae/blebs rarely have complete epithelial lining, and complex alveolus-like structures, if present, are in continuity with surrounding expanded air spaces. This suggests that they originate from simplification of alveolar structures due to the disappearance of alveolar walls rather than de novo development (Fig. 4e,f) . In addition, irregular interstitial fibrosis is absent on the parenchymal side of BHD syndrome-associated subpleural cysts, whereas it is commonly observed in that of emphysematous bullae/blebs. Less frequently encountered but important cystic lung diseases that must be distinguished from BHD syndromeassociated lung disease include collagen vascular diseases such as Sj€ ogren's syndrome and rheumatoid arthritis. 55 Lungs with follicular bronchiolitis, LIP or LCDD involving bronchioles and alveolar septa may form thin-walled cysts. 56 Although they may mimic BHD syndrome-associated cysts, conspicuous lymphoid hyperplasia may be observed in cyst walls adjacent to bronchioles (Fig. 5a,b) . Lymphoplasmacytic infiltration may show clonal proliferation, which can be highlighted by staining for immunoglobulin light chains (k and l) 57 (Fig. 5c,d ). Amyloid deposits, typically as multinodules but also along cyst walls, may be seen in association with LIP-like lymphoplasmacytic infiltration; Congo red and direct fast scarlet stain positively in amyloidosis (Fig. 5e,f) , but not in LCDD despite the presence of eosinophilic material. 57 In premenopausal women presenting with cystic lung lesions, the differential diagnosis should include LAM, endometriosis and metastatic low-grade endometrial stromal sarcoma. 53 Although it is often difficult to distinguish miscellaneous cystic lung diseases from BHD syndrome-associated lung disease 
CONCLUSION AND FUTURE PROSPECTS
Pulmonary cysts and pneumothorax are the most frequent manifestations of BHD syndrome in Japanese patients.
Lung pathology provides us with valuable clues to identify patients that require genetic testing. Pathologists may be the first to recognize the possibility of BHD syndrome after examining lung specimens of previously undiagnosed patients. We hope that this review will help pathologists determine whether patients with cystic lung lesions should be referred to BHD syndrome experts for consideration of genetic testing. Better understanding of the pathology of pulmonary cysts and appropriate monitoring after diagnosis will prevent patients with BHD syndrome and their families from suffering from advanced RCCs.
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